# Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

> **NCT03594149** · PHASE3 · COMPLETED · sponsor: **Centre Henri Becquerel** · enrollment: 60 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT03594149
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-18
- **Primary completion:** 2024-07-17
- **Final completion:** 2024-12-29
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594149, "Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03594149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*